The effect of automated insulin delivery system use on diabetes distress in people with type 1 diabetes and their caregivers: A systematic review and meta‐analysis
Authors' conclusion
This work suggests that AIDs is associated with a DD reduction in adults and caregivers but not in children/teenagers with type 1 diabetes. More longitudinal studies and better systematic DD assessments are needed.
Study context
- Population
- People with T1D (adults, paediatric) and their caregivers; studies until 4 April 2024
- Participants
- 5,426 people40 studies
- Comparison
- AID vs other insulin delivery systems
- Outcome
- Diabetes distress (DD)
Methodological detailsrandom effects models by population and study design, subgroup analysis by age group (children vs teenagers)
- Random effects models by population and study design
- Subgroup analysis by age group (children vs teenagers)
Pooled result
As reported in the abstract
Adults, 8 before-after studies (BAS): significant small diabetes distress (DD) reduction post-AID initiation, SMD
−0.32 (−0.40, −0.24) (95% CI)
Adults, 5 randomised controlled trials (RCTs): significant small DD reduction post-AID initiation, SMD
−0.19 (−0.27, −0.11) (95% CI)
Caregivers, 11 BAS: significant moderate DD reduction
−0.48 (−0.78, −0.18) (95% CI)
Caregivers, 5 RCTs: significant moderate DD reduction
−0.22 (−0.38, −0.06) (95% CI)
Further pooled results
DD by age group (parents of children vs parents of teenagers)
- Increased benefit in parents of children compared to parents of teenagers
Original publication
Composed by AI from the published abstract and checked against it. How Briefs are made →